Saudi Food and Drug Authority (SFDA) has temporarily suspended imports from Gulf Pharmaceutical Industries (Julphar) due to non-compliance with manufacturing regulations, according to the FDA Twitter account.
This decision came after several violations were detected in an FDA inspection.
Comments
{{DisplayName}}
{{ElapsedTime}}